All In Biotech

Free tool

FAERS Monitor: Avopef

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 220200 or its brand name (Avopef, Etoposide). Reports on generic versions are filed under their own applications.

Reports

73,447

Serious

71,494

97% of reports

Hospitalization

24,902

Death reported

17,829

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use8,393
  • febrile neutropenia7,746
  • neutropenia5,069
  • drug ineffective4,759
  • disease progression4,532
  • thrombocytopenia4,140
  • pyrexia3,405
  • anaemia3,353
  • sepsis2,998
  • product use in unapproved indication2,973
  • death2,838
  • pancytopenia2,784
  • pneumonia2,510
  • nausea2,494
  • mucosal inflammation2,345

Reports by year received

View as table
YearReports
2004792
2005881
2006745
2007988
20081,084
20091,045
20101,167
20111,773
20121,995
20131,567
20141,702
20152,269
20162,601
20173,664
20184,656
20194,902
20205,842
20215,788
20226,631
20236,994
20246,507
20255,644
20264,206

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,980,712 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal7,74637.736.9245,361
mucosal inflammationSignal2,34528.126.955,790
pancytopeniaSignal2,78415.014.434,542
disease progressionSignal4,53211.411.041,424
neutropeniaSignal5,06911.110.844,890
thrombocytopeniaSignal4,14011.010.636,312
sepsisSignal2,9987.97.617,617
anaemiaSignal3,3535.14.910,974
product use in unapproved indicationSignal2,9733.53.35,209
pyrexiaSignal3,4052.82.74,073
off label useSignal8,3932.82.79,746
pneumoniaSignal2,5102.22.11,714
drug ineffective4,7591.01.06
death2,8380.90.910
nausea2,4940.90.927

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.